Stada CEO Calls For Dialogue As Satisfaction With European Health Systems Declines

Almost half of Europeans are now dissatisfied with their national health systems, a recent survey by Stada finds. Company CEO Peter Goldschmidt urges for dialogue with governments and health ministries to see how self-care can help “build resilient health systems for the years to come.”

• Source: Shutterstock

Dialogue between the consumer health industry and government is crucial to reverse the continuing decline in satisfaction with health systems among European citizens, argues Stada Arzneimittel CEO Peter Goldschmidt.

Speaking at the launch of the 2024 Stada Health Report, which finds satisfaction with healthcare systems at an “all-time low,” Goldschmidt said that “open dialogue, based on empirical data” was key to “building resilient health systems for the years to come.”

Only 56% of respondents to Stada’s latest survey of 46,033 people across 23 European countries, conducted by Human8, said they were satisfied with the public health system in their country.

“Europeans’ satisfaction with their national healthcare systems is falling. Indeed, barely one in two Europeans is now happy with the level of service they receive, down from three in four satisfied citizens just five years ago,” Goldschmidt commented.

“I’m not really surprised, the trend is obvious,” Goldschmidt added. “People in these countries are waiting for answers but the answers are not there.”

Access Key

Across Europe, difficulties in getting doctors’ appointments were cited as a major reason for this dissatisfaction, followed by a general lack of trust in health authorities, privatization of public health systems and lack of access to preventative health services.

Satisfaction dropped most notably in the UK, with the country losing 11 percentage points since Stada’s last heath report in 2023 – “likely fueled by post-pandemic pressure on the UK National Health Service,” the company suggested – and in Germany, which lost nine percentage points in the year. (Also see "Over A Quarter Of EU Consumers Increase Supplement Intake But Financial Pressures Take Toll" - HBW Insight, 20 September, 2023.)

In countries where levels of satisfaction remain high, like Belgium, Switzerland and the Netherlands, by contrast, access to healthcare professionals, affordable medicines and preventative health services were cited as positives.

In Belgium, Stada has an active dialogue with the local health ministry, Goldschmidt noted.

Self-Care Solution

Given the link to availability of medicines and preventative health services, satisfaction with healthcare systems “could be linked to regular self-care,” Stada suggests in its report.

“People who regularly engage in self-care are more likely to be happy with the healthcare system than those who reportedly do little to support their own health,” the company writes.

The good news is that 89% of Europeans currently engage in activities to support their overall wellbeing. Behind physical exercise and healthy eating, taking vitamins and nutritional supplements is one of the most popular such activities.

Just under a third of Europeans surveyed by Stada said they take such products, with VMS use in the Czech Republic, Slovakia and Poland higher than average.

More from Europe

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By 

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.

Plenty For Industry To Do As EU Wastewater Directive Faces Legal Challenges

 
• By 

Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.

French Agency Proposes Effective EU Ban On CBD In Foods And Cosmetics

 
• By 

France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.

Clasado Divests Bimuno Prebiotic Consumer Brand To UK’s Eleat

 
• By 

Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.

More from Geography

EU Parliament Agrees To Postpone Due Diligence And Sustainability Reporting Rules

 
• By 

Speaking at a recent AESGP webinar, sustainability expert Onur Durmus called the the European Commission’s “Omnibus” proposals - designed to simplify ESG reporting rules and recently supported by EU Parliament - a “positive development” for the European consumer health industry.

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By 

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

Over The Counter: Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls

 
• By 

HBW Insight catches up with PAGB CEO Michelle Riddalls to chat about the association's new five year plan. Riddalls also reflects on the successes of the last five years, including relaunching the UK Reclassification Alliance, which has published a list of Rx-to-OTC switches the government would like to see applications for. Part one of two.